Advanced Search

Medical Microbiology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Jorg Hacker

    Jorg Hacker

    Deutsche Akademie der Naturforscher Leopoldina, National Academy of Sciences, Halle, Germany

  • Photo of Ira F Salkin

    Ira F Salkin

    Information From Science, LLC, West Sand Lake, NY, USA

Section Topics

  • » Animal models
  • » Anti-fungal susceptibility testing
  • » Diagnosis
  • » Epidemiology
  • » Gene regulation & variability
  • » Molecular taxonomy
  • » Pathogenicity mechanisms
  • » Resistance mechanisms
  • » Vaccines

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

14
The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.

Sanada T, Kim M, Mimuro H, Suzuki M, ..., Gohda J, Inoue J, Mizushima T, Sasakawa C. Nature. 2012 Mar 29; 483(7391):623-6

4 Evaluations, most recent by

Christoph Dehio and Arto Pulliainen, University of Basel, Switzerland. F1000 Microbiology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.